Apraclonidine 0.5% ophthalmic solution is indicated for short-term adjunctive therapy, in patients on maximally tolerated medical therapy, who require additional IOP reduction.
It may take some time to load the article after you tap to read more.
Tap here to know more...... DailyMed (which is maintained by National Library of Medicine)
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=de798d0d-a93c-40fb-95ea-10a4e6b287b7&type=display
